We follow the science, to unlock innovation and pursue sustainable answers. We are guided by our commitment to patients, our people and the planet. Our vision is to deliver life-transforming treatments to those in need. We are steadfast in our purpose for better health for people and a brighter future for the world.
关于我们
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines
- 网站
-
https://www.takeda.com/
Takeda的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Tokyo
- 类型
- 上市公司
- 创立
- 1781
- 领域
- Pharmaceuticals、Therapeutics、Oncology、Gastroenterology和Vaccines
地点
Takeda员工
-
Joseph Horvath
Head of Quality Risk Management at Takeda
-
David Swaddle
Digital innovator, Learning leader, community builder, technical tinkerer. All opinions and views are my own and not my employer's.
-
Mark Kamensek
Associate Director, Human Factors & User Experience
-
Martin Friederich
Head of Finance & Supply Switzerland at Takeda
动态
-
To transform the lives of patients who need therapy today, and those who could benefit from it tomorrow, our Plasma-Derived Therapies (PDT) team is reimagining discovery, donation, manufacturing and delivery across our entire end-to-end operations—from donor to patient, vein to vein.? Jacqueline Koch, Head of Global Regulatory Program Strategy, finds working on this “vein to vein chain” the most rewarding part of her job." Our PDT regulatory affairs team works to develop innovative regulatory strategies to bring new therapies to patients worldwide.? Join an innovative team that’s making a difference in patients’ lives. Explore open PDT roles today:??https://lnkd.in/evxRMfGj
-
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disease, which causes symptoms such as muscle weakness, numbness, and difficulty walking. Early diagnosis and treatment are important in helping patients have the best opportunity for improved function and physical well-being. Learn more about #CIDP
-
Lindsey is an invaluable member of our team, highlighting our Career Move – Empower. Her leadership, strategic decision making and mentoring has been essential in driving our organization's success. Lindsey's transition from site engineering to product operations within Strategy and Business Excellence showcased her ability to lead diverse teams. By embracing various perspectives and adjusting her communication style, Lindsey successfully achieved ambitious goals, highlighting her capacity to guide and inspire her team. Lindsey led a project to develop a process for regulatory compliance in complex markets, resulting in a playbook that aligns diverse cultures and functions. Learn more about Lindsey's career story: https://lnkd.in/eCiFd7iV #MakeHistoryChangeFutures #TeamTakeda
-
We're excited to announce that our team will be sharing new findings in the dengue landscape at the 2024 International Congress on Infectious Diseases, with 2 detailed posters. Don’t miss the opportunity to learn more about our latest research and insights. Join us at Takeda's booths #17 & #26 during the Congress! #ICID #DengueResearch #MedicalCongress #GlobalHealth #ICIDCongress2024 #dengue #ICID2024
-
We're excited to share our latest breakthrough in sustainable technology! By developing a new method to separate aluminum foil from plastic, we can now recycle both materials more effectively, significantly reducing our environmental impact. To spread the positive effects of this innovation, we're sharing our insights with other pharmaceutical companies, encouraging them to adopt this eco-friendly process. We're proud to announce that we have been honored with the FY2024 #3Rs (Reduce, Reuse, Recycle) Promotion Merit Award from the Ministry of Economy, Trade and Industry (METI) for this achievement. Read the full press release here: https://lnkd.in/eVYVAix2
-
Psoriasis can present differently across various skin tones and textures. Hear from Simmie – a person living with #psoriasis – on racial biases that she experienced with this condition, and the lack of diverse imagery on how psoriasis presents on darker skin. By fostering inclusivity in clinical research, we can move toward more equitable care and better outcomes for all. https://lnkd.in/edjXNsHd??
-
We are delighted to announce the successful topping-off ceremony for our new R&D site in Vienna, Austria. In the company of esteemed representatives from government, business, academia, and many Takeda colleagues, we celebrated this significant milestone in the construction of our “Lab of the Future.” This cutting-edge, environmentally sustainable facility will enable our scientists to develop groundbreaking therapies for diseases with high unmet needs, utilizing the latest technologies and innovative systems. Learn more about this exciting project: https://lnkd.in/ed8uu6SG #Labofthefuture #sustainability #Innovation
-
We leave #ACR24 inspired, having shared multiple abstracts detailing recent data in #PsoriaticArthritis while connecting with other researchers who share a common goal: to find better options for people living with this condition. American College of Rheumatology
-
What does paper have to do with creating better health for people and a brighter future for the world? More than you might think. Read about how we exceeded our recycled packaging goal by 3% and 2 years: https://lnkd.in/dNmJTwtQ #OurStories